Monoclonal antibodies and autologous stem cell transplantation for lymphoma
- 1 March 2001
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 27 (6) , 565-569
- https://doi.org/10.1038/sj.bmt.1702857
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 23 references indexed in Scilit:
- Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.Transplantation and Cellular Therapy, 2000
- Rituximab (Anti‐CD20) Therapy of B‐Cell Lymphomas: Direct Complement Killing is Superior to Cellular Effector MechanismsScandinavian Journal of Immunology, 2000
- Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s LymphomasJournal of Clinical Oncology, 2000
- Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+B-Cell Non-Hodgkin's LymphomaJournal of Clinical Oncology, 1999
- Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular LymphomaBlood, 1999
- In vivo‘Purging’ of residual disease in CLL with Campath‐1HBritish Journal of Haematology, 1997
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991
- The CAMPATH‐1 antigen (CDw52)Tissue Antigens, 1990
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975